Multivalent Ligand-Receptor Binding on Lipid Bilayers
脂质双层上的多价配体-受体结合
基本信息
- 批准号:7228928
- 负责人:
- 金额:$ 22.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:2,4-DinitrophenolAffectAntibodiesAttenuatedBehaviorBindingBinding SitesBiological ModelsCell surfaceCellsCeramidesChemistryCholera ToxinCholera Toxin Protomer BCholesterolDNA Sequence RearrangementDataDefectDevelopmentDiffusionDiseaseDissociationEquilibriumEventExtracellular ProteinFab ImmunoglobulinsGanglioside GM1HaptensImmunoglobulin GIndividualInvestigationLaboratoriesLateralLeadLecithinLigand BindingLigandsLinkLipid BilayersLipidsLiquid substanceMeasurementMembraneMembrane LipidsMembrane MicrodomainsMicrofluidicsMicroscopyModelingPhasePhospholipidsPlayProteinsResearchRoleSideSiteSpectrum AnalysisSphingolipidsStructureSurfaceSystemTailTestingdensitydinitrophenylin vivoinhibitor/antagonistinterestpathogenreceptorreceptor bindingresearch studytwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): The long-term focus of the research in this proposal is to understand the role of lipid membrane composition on multivalent ligand/receptor binding. Recent developments with model bilayer systems have shown that structured liquid-ordered regions rich in cholesterol and sphingolipids can coexist along side a phospholipid rich, liquid-disordered domain. It is still controversial as to whether these "lipid rafts" also exist in cells; however, there has been speculation that if they do exist in vivo, they could significantly enhance multivalent ligand-receptor attachment. The mechanism might involve either concentrating membrane bound ligands into small highly concentrated regions or changing the ligand orientation to make binding with external proteins more favorable. The hypothesis that membrane composition and orientation can directly affect the equilibrium dissociation constants of multivalent binding will be tested for IgG antibodies (a bivalent system) and for cholera toxin (a pentavalent system). Both initial binding as well as subsequent lateral binding will be explored using newly developed high-throughput microfluidic strategies. Such fundamental studies may ultimately play a role in developing inhibitors to the initial step of pathogen entry into cells. The four specific aims of this proposal include: (1) investigating the initial binding event for anti-2,4 DNP IgG with its lipid conjugated hapten. Studies will be conducted as a function of cholesterol content as this may force the ligand out of the membrane; hence, making it more available. (2) Investigations of the second dissociation constant for antibodies will be conducted. This will be done as a function of cholesterol content, ligand density, and sites of unsaturation in the lipid tails. One central hypothesis is that components which attenuate the diffusion constant of the membrane may also impede lateral binding interactions. (3) The effect of lipid raft formation on binding will be undertaken. Mixtures of cholesterol/sphingolipid/phospholipid will be probed for their ability to affect both the initial and subsequent binding interactions in membranes. Measurements of binding will be made in both the phospholipid-rich and sphingolipid-rich phases when possible. (4) The above three aims will be expanded to cholera toxin/GM1. This system should show dramatically different behavior because GM1 is known to form clusters, rather than acting as an ideal dilute constituent of the membrane. The binding constant may change dramatically above a critical concentration.
描述(由申请人提供):该提案中研究的长期重点是了解脂质膜组成在多价配体/受体结合中的作用。使用模型双层系统的最新发展表明,富含胆固醇和鞘脂的结构化液体排序区域可以与富含磷脂的富含磷脂的液体共存。关于这些“脂质筏”是否也存在于细胞中,仍然存在争议。但是,有人猜测,如果它们确实存在于体内,它们可能会显着增强多价配体受体附着。该机制可能涉及将膜结合的配体浓缩到小型高度浓缩区域,或更改配体方向以使与外部蛋白质的结合更有利。膜组成和方向可以直接影响多价结合的平衡分离常数的假设将用于IgG抗体(一种二价系统)和霍乱毒素(五体含量系统)。最初的结合以及随后的侧向结合都将使用新开发的高通量微流体策略探索。这样的基本研究最终可能在开发病原体进入细胞的初始步骤中发挥作用。该提案的四个具体目的包括:(1)研究抗2,4 DNP IgG的初始结合事件及其脂质共轭触觉。研究将作为胆固醇含量的函数进行,因为这可能会迫使配体从膜上伸出。因此,使其更可用。 (2)将对抗体的第二个解离常数进行研究。这将是胆固醇含量,配体密度和脂质尾部不饱和位点的函数。一个中心假设是减弱膜扩散常数的成分也可能阻碍横向结合相互作用。 (3)将进行脂质筏形成对结合的影响。将探测胆固醇/鞘脂/磷脂的混合物,以影响膜中初始结合相互作用和随后的结合相互作用的能力。在可能的情况下,将在富含磷脂的富含磷脂和富含鞘脂的相中进行结合的测量。 (4)以上三个目标将扩展到霍乱毒素/GM1。该系统应该显示出截然不同的行为,因为已知GM1形成簇,而不是充当膜的理想稀释成分。结合常数可能在临界浓度以上发生巨大变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Cremer其他文献
Paul Cremer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Cremer', 18)}}的其他基金
Creating Platforms for the Proteomics and Membrane Proteins
为蛋白质组学和膜蛋白创建平台
- 批准号:
8000155 - 财政年份:2010
- 资助金额:
$ 22.81万 - 项目类别:
Creating Platforms for the Proteomics and Membrane Proteins
为蛋白质组学和膜蛋白创建平台
- 批准号:
7994169 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Multivalent Ligand-Receptor Binding on Lipid Bilayers
脂质双层上的多价配体-受体结合
- 批准号:
6948417 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Multivalent Ligand-Receptor Binding on Lipid Bilayers
脂质双层上的多价配体-受体结合
- 批准号:
6759194 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Multivalent Ligand-Receptor Binding on Lipid Bilayers
脂质双层上的多价配体-受体结合
- 批准号:
6872900 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Creating Platforms for the Proteomics and Membrane Proteins
为蛋白质组学和膜蛋白创建平台
- 批准号:
8204404 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Creating Platforms for the Proteomics and Membrane Proteins
为蛋白质组学和膜蛋白创建平台
- 批准号:
7580724 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Multivalent Ligand-Receptor Binding on Lipid Bilayers
脂质双层上的多价配体-受体结合
- 批准号:
7038306 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
Creating Platforms for the Proteomics and Membrane Proteins
为蛋白质组学和膜蛋白创建平台
- 批准号:
8598737 - 财政年份:2004
- 资助金额:
$ 22.81万 - 项目类别:
相似国自然基金
YTHDF3调控CXCL13表达影响黑色素瘤免疫微环境及PD-1抗体疗效的机制
- 批准号:82303866
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
AID介导抗体重链非编码区重组调控质膜BCR密度并影响记忆B细胞命运决定的研究
- 批准号:32370948
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
- 批准号:82360402
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
心衰患者中单克隆β1-肾上腺素受体自身抗体的筛选及其对受体构象影响的研究
- 批准号:32271156
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
A Universal CAR-NK Cell Targeting Various Epitopes of HIV-1
一种针对 HIV-1 多种表位的通用 CAR-NK 细胞
- 批准号:
10215523 - 财政年份:2020
- 资助金额:
$ 22.81万 - 项目类别:
A Universal CAR-NK Cell Targeting Various Epitopes of HIV-1
一种针对 HIV-1 多种表位的通用 CAR-NK 细胞
- 批准号:
10083117 - 财政年份:2020
- 资助金额:
$ 22.81万 - 项目类别:
Regulation of Mast Cell Development and Function
肥大细胞发育和功能的调节
- 批准号:
7904354 - 财政年份:2009
- 资助金额:
$ 22.81万 - 项目类别:
Metabolic Discrimination of Unknown Bacterial Pathogens
未知细菌病原体的代谢区分
- 批准号:
7350154 - 财政年份:2005
- 资助金额:
$ 22.81万 - 项目类别:
Metabolic Discrimination of Unknown Bacterial Pathogens
未知细菌病原体的代谢区分
- 批准号:
7178451 - 财政年份:2005
- 资助金额:
$ 22.81万 - 项目类别: